🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Artivion, Inc.

AORT Healthcare
$22.46 $-0.31 (-1.36%)
Market Cap: $1.09 B
Gurus Holding
5
Popularity Rank
#1742
% of Shares Held
1.63%
Net Activity (Q1 2026)
+$541,133.33

Guru Ownership Trend

Guru Analysis for Artivion, Inc. (AORT)

Artivion, Inc. (AORT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $17.77 M.

Top institutional holders include Chuck Royce and First Eagle Investment.

Institutional sentiment is currently Bullish. This is evidenced by a $541,133.33 net inflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position. Conversely, Joel Greenblatt reduced exposure by 23.6%.

Key Holders

Top 5 by Value

$15.57 M
$781,983
$670,000
$538,680

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$982,038.07
Total Buy Value
New Buys 1
Additions 2
-$440,904.74
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
2
Net Buyers
3

FAQs for Artivion, Inc. (AORT)

Major holders include Chuck Royce ($15.57 M), First Eagle Investment ($11.41 M), Jefferies Group ($781,983). According to the latest reported data, 5 tracked investment managers collectively hold approximately 791,243 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $541,133.33, with 3 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited AORT. The total reported sell value was $440,904.74.

Yes, 1 managers opened new positions in AORT, and 2 increased their existing holdings. The total reported buy value was $982,038.07.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.15% Reduce -1.7% 425,282 $15.57 M Q1 2026
0.02% Add 1.5% 311,601 $11.41 M Q1 2026
0.01% New Buy 21,354 $781,983 Q1 2026
0.00% Add 4.3% 18,296 $670,000 Q1 2026
0.00% Reduce -23.6% 14,710 $538,680 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form